Motif Bio Share Discussion Threads

[scottdavid70] 30/3/2021 19:03

Do you think I am selling them?

No I want mass market appeal so it will be free to download on Audible and Kindle. Will let you know when it drops

[bi11y ray va1entine] 30/3/2021 13:37

If everyone on this board buys a copy you'll sell five copies. They won't though.

[scottdavid70] 30/3/2021 11:03

Laughable stuff isn’t Chuffer - the aroma of BS is overwhelming

[scottdavid70] 29/3/2021 23:10

Already got the book syndicated when this shower have finished showering the investors - they can’t push the attempt at investor and public apathy back much longer as even they will run out of the Lombard Odier Trust Fund soon they set up for themselves

[he35enb56g] 29/3/2021 21:18

"Zero consequences except when my book is published to their reputations"That's on a very big assumption that anyone will actually read your book so will probably stay at ZERO for both lol.

[scottdavid70] 29/3/2021 17:32

Amazing you can get paid £50,000 a month and be in line for a £50,000 a month salary and miss deadlines like England miss penalties.

Zero consequences except when my book is published to their reputations.

Never an acknowledgment of the shareholders they let down every time a RNS is issued that doesn’t follow through on their one self stated timetable

Amateurs except for trousering unearned salaries and bonuses - on that front they have no equals

[scottdavid70] 29/3/2021 17:29

LSE lackeys saying the ‘no assurances’ line is in every RNS - incorrect the RNS on the 26th February didn’t include it - it back in now

Am sure it’s just an audit issue - cough cough

[small crow] 29/3/2021 15:23

Think of it like this - if this was Butch Cassidy losing his shirt in a saloon card game, would he walk away to fight another day or start crying and not stop for two years? The latter would not make for a good film unless you like ChicFlics.

[small crow] 29/3/2021 15:21

Could be. That's why it's always gambling.

[small crow] 29/3/2021 15:10

It will be lawyers. It's always lawyers.

[lithological heterogeneities] 29/3/2021 14:29

Excellent RNS this morning:

"Many of the key work streams of the Proposed Transaction are now substantially complete."

Looking VERY promising now.
Looking forward to late Apr/early May.

[petersmith6] 29/3/2021 12:07

Think it's a bit of both. I've made a few million on reverse take over but the stress over due diligence..legal and regulatory scrutiny and Secreticey can take its toll. We lost 12 million when some idiot leaked some information online and the boiler rooms screwed with the price.

[chuffer2] 29/3/2021 11:13

Is it incompetence or just pure corruption....?????
I think l know that answer

[scottdavid70] 29/3/2021 11:10

They have also never apologies for anything- failing - being late - nothing

Embarrassing humans

[scottdavid70] 29/3/2021 10:55

The pungent aroma of BS is radiating from this RNS like the words ‘no clinical trials’ did from Lumsden on the 19th Feb 2019

See it for what it is - there will be no RTO now

[petersmith6] 29/3/2021 10:47

I've been involved in a few RTO's and 90 % is picking through the papers and legal stuff so the delays don't surprise me. But I get the feeling they haven't got a very good idea how to rto

[scottdavid70] 29/3/2021 09:11

So this audit work wasn’t known at the end of January? Haha really Jonathan has Graham put you up to this?

So you have mislead another target by months - laughable stuff

[scottdavid70] 29/3/2021 09:06

Literally no one surprised by this RNS

Millions the last £50,000 in May and then switch the lights of behind you Jonathan.

Can’t get the funding - pretty obvious isn’t?

[perfectstorm] 29/3/2021 07:36

The shenanigans of this BOD are almost funny. I just hope that people aren't hanging on for good news because there wont be any. This story has been over for a very long time.

[moneymunch] 29/3/2021 07:06

RNS Number : 7104T
Motif Bio PLC
29 March 2021






Motif Bio plc

("Motif" or the "Company")



Update re proposed Reverse Takeover



Motif Bio plc (AIM: MTFB), which has been reclassified as an AIM Rule 15 cash shell, provides a further update regarding the proposed reverse takeover pursuant to AIM Rule 14 ("Reverse Takeover") that was outlined in the Company's announcements of 5 January 2021 and 27 January 2021.



Motif continues to progress a Reverse Takeover under a heads of terms agreement with a UK-based ADC (Antibody-Drug Conjugate) discovery and development company (the "Target"), as a result of which, subject to, among other matters, the execution of a sale and purchase agreement, Motif would acquire the entire issued share capital of the Target (the "Proposed Transaction").



Motif will remain suspended from trading while the Proposed Transaction is negotiated and advanced, and the Company will provide shareholders with further updates as appropriate.



Many of the key work streams of the Proposed Transaction are now substantially complete. However, as a result of additional audit work which is required for the year ended 31 December 2020, marketing is now not expected to commence until the second half of April 2021. As such, should the Proposed Transaction proceed, it is expected that Motif will now publish the AIM Admission Document in late April or early May 2021.



At present there can be no assurances that Motif will be able to complete the Proposed Transaction and as a consequence the Company's admission to trading on AIM may be cancelled.



The person responsible for the release of this announcement on behalf of Motif is Jonathan Gold, President and Chief Business Officer.